Navigation Links
N30 Pharma Announces License Agreement With NitroMed, Inc.
Date:10/29/2007

BOULDER, Colo., Oct. 29 /PRNewswire/ - N30 Pharma (N30), a biopharmaceutical company focused on the discovery, development, and commercialization of respiratory drugs that target endogenous s-nitrosothiols, today announced a licensing agreement with NitroMed Inc. (Nasdaq: NTMD) covering the respiratory use of a s-nitrosothiol drug candidate. Financial terms of the deal were not disclosed.

"I am extremely pleased to announce this agreement. NitroMed is a leader in exploring the medical utility of Nitric Oxide and s-nitrosothiol therapies, and has foundational intellectual property in the area," commented Charles Scoggin, M.D., Chairman of N30 Pharma.

N30 Pharma is developing s-nitrosothiol therapies for critical unmet needs in important respiratory diseases such as cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease (COPD). S-nitrosothiols are endogenous molecules that store and transduce nitric oxide, and are critical modulators of airway and vascular smooth muscle tone, as well as having other effects. N30 is a privately held company headquartered in Boulder, Colorado.


'/>"/>
SOURCE N30 Pharma
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...
(Date:12/14/2009)... State Biotech Leaders to Develop Blueprint to ... while Boosting Rhode Island,s Growing Biotech and ... Dec. 14 Several of Rhode ... and biotechnology gathered today at Brown University,s ... of medical innovation in Rhode Island and ...
(Date:12/14/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... $2 billion aggregate principal amount of its senior notes ... offering consists of $850 million of 4.50 percent notes ... due January 2020 and $300 million of 7.375 percent ... use the net proceeds for general corporate purposes, including ...
(Date:12/14/2009)... Calif., Dec. 14 Nektar Therapeutics (Nasdaq: ... has been appointed to serve on its board ... industry leader with over 35 years of experience ... "Dennis brings to Nektar extensive industry perspective at ... Howard W. Robin, President and CEO of Nektar ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... a Stand-Alone Product , , ... used a one-of-a-kind air filtration technology in a bid to ... environmental design. , , The ... Geographic earn three points for its LEED-EB 2.0* re-certification application ...
... SharpBrains, will lead a webinar discussing the Top 10 Cognitive Fitness ... ... San Francisco, CA (PRWEB) December 2, 2008 -- Alvaro ... Council on the Challenges of Gerontology, will lead a webinar discussing ...
... Imagine a self-powering cell phone that never needs to ... the user into the energy it needs to keep ... thanks to the recent work of Tahir Cagin, a ... at Texas A&M University. , Utilizing materials known in ...
Other Biology Technology:National Geographic Uses Air Filtration in Bid To Be an Energy, Environmental Leader 2Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar 2Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar 3Self-powered devices possible, says Texas A&M researcher 2Self-powered devices possible, says Texas A&M researcher 3
(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...
(Date:12/14/2009)... HOUSTON -- (Dec. 14, 2009) -- Researchers at Rice ... a single nanoparticle that can be tracked in real ... cells, tags them with a fluorescent dye and kills ... the first examples from a growing field called "theranostics" ... treat diseases in a single procedure. , The research ...
(Date:12/14/2009)... by sneezing, touching, or for Tasmanian devils ... may have driven the dinosaurs to extinction through the ... member of f1000 Biology, highlights the ,paleobiological detective work, ... This led them to deduce that a protozoan parasite ... in many tyrannosaurid fossils. , The parasite,s modern-day equivalent, ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Tracking new cancer-killing particles with MRI 2Giving Statins to Kids Provokes Debate 52716 1Giving Statins to Kids Provokes Debate 52716 2Giving Statins to Kids Provokes Debate 52716 3SEIU Security Officers Who Protect Kaiser Permanente Hospitals Nationwide Vote Overwhelmingly to Ratify First Ever Union Contract 52712 1SEIU Security Officers Who Protect Kaiser Permanente Hospitals Nationwide Vote Overwhelmingly to Ratify First Ever Union Contract 52712 2SpeechEasy Seeks Proposals For Future Research Studies 52708 1SpeechEasy Seeks Proposals For Future Research Studies 52708 2SpeechEasy Seeks Proposals For Future Research Studies 52708 3
... social groups, and that includes humans, blindly following a leader ... animals have developed simple but effective behaviour to follow where ... rather than follow a single group member. , This pattern ... an individual as the group recognise that consensus is better ...
... exists much ethical controversy brought about by advances in biology ... essay in The Journal of Law, Medicine & Ethics, Laurie ... Jewish texts, traditions, and philosophy to show how acting to ... , Genetic explanations for how the natural world functions and ...
... abnormal protein levels in diabetic retinopathy , Journal ... reporting an advance in bridging huge gaps in medical ... eyes of individuals with diabetic retinopathy (DR) a ... In a study scheduled for the June 6 issue ...
Other Biology News:When following the leader can lead into the jaws of death 2When following the leader can lead into the jaws of death 3Religion and the narrative of biological science 2American Chemical Society’s Weekly PressPac -- May 7, 2008 2American Chemical Society’s Weekly PressPac -- May 7, 2008 3American Chemical Society’s Weekly PressPac -- May 7, 2008 4American Chemical Society’s Weekly PressPac -- May 7, 2008 5American Chemical Society’s Weekly PressPac -- May 7, 2008 6American Chemical Society’s Weekly PressPac -- May 7, 2008 7American Chemical Society’s Weekly PressPac -- May 7, 2008 8
Request Info...
... fastest automated perfusion system. For real-time ... physiology, biophysics, electrochemistry, or general liquid-handling ... 1.5-4 millisecond accuracy Run experiments ... for accuracy and flexibility Turnkey ...
Recombinant Human PTP1B (aa 2-321), CF...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant rat ... serum. Each kit contains sufficient materials to ... provided that the following conditions are met: ...
Biology Products: